224 related articles for article (PubMed ID: 27013471)
1. Epigenetic Downregulation of Scn3a Expression by Valproate: a Possible Role in Its Anticonvulsant Activity.
Tan NN; Tang HL; Lin GW; Chen YH; Lu P; Li HJ; Gao MM; Zhao QH; Yi YH; Liao WP; Long YS
Mol Neurobiol; 2017 May; 54(4):2831-2842. PubMed ID: 27013471
[TBL] [Abstract][Full Text] [Related]
2. Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippocampus during postnatal development and seizure condition.
Li HJ; Wan RP; Tang LJ; Liu SJ; Zhao QH; Gao MM; Yi YH; Liao WP; Sun XF; Long YS
Biochim Biophys Acta; 2015 Jan; 1849(1):1-9. PubMed ID: 25459751
[TBL] [Abstract][Full Text] [Related]
3. GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions.
Lin GW; Lu P; Zeng T; Tang HL; Chen YH; Liu SJ; Gao MM; Zhao QH; Yi YH; Long YS
Neuropharmacology; 2017 Feb; 113(Pt A):480-489. PubMed ID: 27816501
[TBL] [Abstract][Full Text] [Related]
4. Valproate-Induced Epigenetic Upregulation of Hypothalamic Fto Expression Potentially Linked with Weight Gain.
Zhang H; Lu P; Tang HL; Yan HJ; Jiang W; Shi H; Chen SY; Gao MM; Zeng XD; Long YS
Cell Mol Neurobiol; 2021 Aug; 41(6):1257-1269. PubMed ID: 32500354
[TBL] [Abstract][Full Text] [Related]
5. SCN3A deficiency associated with increased seizure susceptibility.
Lamar T; Vanoye CG; Calhoun J; Wong JC; Dutton SBB; Jorge BS; Velinov M; Escayg A; Kearney JA
Neurobiol Dis; 2017 Jun; 102():38-48. PubMed ID: 28235671
[TBL] [Abstract][Full Text] [Related]
6. Promoter analysis of mouse Scn3a gene and regulation of the promoter activity by GC box and CpG methylation.
Deng GF; Qin JM; Sun XS; Kuang ZY; Su T; Zhao QH; Shi YW; Liu XR; Yu MJ; Yi YH; Liao WP; Long YS
J Mol Neurosci; 2011 Jun; 44(2):115-21. PubMed ID: 21271300
[TBL] [Abstract][Full Text] [Related]
7. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model.
Luszczki JJ; Sawicka KM; Kozinska J; Borowicz KK; Czuczwar SJ
Epilepsy Res; 2007 Aug; 76(1):66-72. PubMed ID: 17659862
[TBL] [Abstract][Full Text] [Related]
8. Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model.
Barker-Haliski ML; Dahle EJ; Heck TD; Pruess TH; Vanegas F; Wilcox KS; White HS
J Pharmacol Exp Ther; 2015 May; 353(2):318-29. PubMed ID: 25755209
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic induction of melatonin MT
Bahna SG; Niles LP
Eur Neuropsychopharmacol; 2017 Aug; 27(8):828-832. PubMed ID: 28648552
[TBL] [Abstract][Full Text] [Related]
10. M-current preservation contributes to anticonvulsant effects of valproic acid.
Kay HY; Greene DL; Kang S; Kosenko A; Hoshi N
J Clin Invest; 2015 Oct; 125(10):3904-14. PubMed ID: 26348896
[TBL] [Abstract][Full Text] [Related]
11. Valproate administration to mice increases hippocampal p21 expression by altering genomic DNA methylation.
Aizawa S; Yamamuro Y
Neuroreport; 2015 Oct; 26(15):915-20. PubMed ID: 26339990
[TBL] [Abstract][Full Text] [Related]
12. Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients.
Tremolizzo L; Difrancesco JC; Rodriguez-Menendez V; Riva C; Conti E; Galimberti G; Ruffmann C; Ferrarese C
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):47-51. PubMed ID: 22584634
[TBL] [Abstract][Full Text] [Related]
13. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain.
Dong E; Chen Y; Gavin DP; Grayson DR; Guidotti A
Epigenetics; 2010; 5(8):730-5. PubMed ID: 20716949
[TBL] [Abstract][Full Text] [Related]
14. Early Postnatal Treatment with Valproate Induces
Ishiyama M; Tamura S; Ito H; Takei H; Hoshi M; Asano M; Itoh M; Shirakawa T
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635390
[
